Imugene Ltd has released a press release.
Azer-cel Data from CAR T naive cohort in ASCO 2026 abstract
Earlier from Imugene
- Diamond Equity Research Releases Update Note on Imugene Limited (ASX: IMU)
- Prospectus
- $20M placement and SPP, convertible notes amended
- 100% and 80% ORRs in Subset Indications in azer-cel study